Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
78
Frequently Asked Questions
What is Market Cap of Dianthus Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dianthus Therapeutics Inc market cap is $1.46B.
What is the 52-week high for Dianthus Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dianthus Therapeutics Inc 52 week high is $39.87 as of September 28, 2025.
What is the 52-week low for Dianthus Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dianthus Therapeutics Inc 52 week low is $13.37 as of September 28, 2025.
What is Dianthus Therapeutics Inc stock price today?
Dianthus Therapeutics Inc stock price today is $36.71.
What was Dianthus Therapeutics Inc stock price yesterday?
Dianthus Therapeutics Inc stock price yesterday was $35.84.
What is the PE ratio of Dianthus Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dianthus Therapeutics Inc’s P/E ratio is -11.28.
What is the Price-to-Book ratio of Dianthus Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dianthus Therapeutics Inc P/B ratio is 3.8973.
What is the 50-day moving average of Dianthus Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dianthus Therapeutics Inc 50-day moving average is $26.48.
How many employess does Dianthus Therapeutics Inc has?